Security key
98420Q306
XORTX Therapeutics Inc. - Common Shares, no par value per share (XRTX)
CUSIP: 98420Q306
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 47
- Total 13F value
- $19
- Share change
- -230,650
- SEC-reported price per share
- $0.40
- Number of holders
- 1
- Value change
- -$123,543
- Number of buys
- 1
- Number of sells
- 6
- Shares outstanding
- 5,782,525
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
1
Top holders
1
XRTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
XORTX Therapeutics Inc. SEC filings
XORTX Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420Q306
Recent filing periods:
Ownership snapshot
Top reported holders of XRTX - XORTX Therapeutics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lincoln Alternative Strat...
Disclosed value leader
Lincoln Alternative Strat...
Comparable rows
8/8
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Lincoln Alternative Strategies LLC
Showing 1-6 of 8 holder rows.
Quick read
Lincoln Alternative Strategies LLC leads the comparable SEC ownership view at 9.9%.
8 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lincoln Alternative Strategies LLC's linked filing trail.
Comparable ownership
Top 5
Lincoln Alternative Strategies LLC
9.9%
ARMISTICE CAPITAL, LLC
5%
DRW Securities, LLC
3.3%
Baader Bank Aktiengesellschaft
0.32%
TWO SIGMA SECURITIES, LLC
0.22%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lincoln Alternative Strategies LLC |
13D/G
|
9.9%
|
$498,049
572,470 shares
|
$0 | 23 Oct 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$183,372
178,031 shares
|
-$173,839 | 31 Mar 2025 |
| DRW Securities, LLC |
13F
Company
|
3.3%
|
$108,802
193,599 shares
|
— | 31 Dec 2025 |
| Baader Bank Aktiengesellschaft |
13F
Company
|
0.32%
|
$4,737
18,732 shares
|
— | 31 Dec 2025 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
0.22%
|
$7,080
12,597 shares
|
— | 31 Dec 2025 |
| ROYAL BANK OF CANADA |
13F
Company
|
0.07%
|
$2,000
4,091 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
47
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
6
Q1 2026 holders
1
Holder diff
-5
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend